Fig 2.
MIC distributions for Gram-positive clinical isolates collected in Europe, North America, and South America in 2002, before the introduction of daptomycin for clinical use. (Based on data from reference 56.)
MIC distributions for Gram-positive clinical isolates collected in Europe, North America, and South America in 2002, before the introduction of daptomycin for clinical use. (Based on data from reference 56.)